Health officials anticipate 6 million H1N1 vaccine doses by early October

U.S. health officials announced Thursday that "[m]ore than six million doses of swine flu vaccine will be available by the first week in October, more that twice as many as had been recently expected," The New York Times reports. Most of that vaccine "will be the FluMist nasal spray, which is recommended only for people ages 2 to 49 and not for pregnant women or people with health problems" (McNeil, 9/25).

CNN: "There will be more than enough doses of the H1N1 vaccine to go around in the United States, Health and Human Services Secretary Kathleen Sebelius said Thursday. 'The notion that because target groups are supposed to get it first, that there won't be enough, that we're leaving people behind, needs to be corrected,' Sebelius said at a White House briefing" (Cohen and Willingham, 9/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer